PSMF1
Basic information
Region (hg38): 20:1113240-1189415
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (42 variants)
- not_provided (4 variants)
- Complex_neurodevelopmental_disorder_with_motor_features (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PSMF1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000006814.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 42 | 45 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 42 | 3 | 2 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PSMF1 | protein_coding | protein_coding | ENST00000335877 | 7 | 66691 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.31e-8 | 0.185 | 125713 | 0 | 35 | 125748 | 0.000139 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0597 | 171 | 169 | 1.01 | 0.00000952 | 1749 |
Missense in Polyphen | 55 | 56.567 | 0.97229 | 562 | ||
Synonymous | 0.0833 | 67 | 67.9 | 0.987 | 0.00000373 | 563 |
Loss of Function | 0.236 | 12 | 12.9 | 0.929 | 6.35e-7 | 149 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000337 | 0.000337 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000490 | 0.000489 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000124 | 0.000123 |
Middle Eastern | 0.000490 | 0.000489 |
South Asian | 0.000196 | 0.000196 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Plays an important role in control of proteasome function. Inhibits the hydrolysis of protein and peptide substrates by the 20S proteasome. Also inhibits the activation of the proteasome by the proteasome regulatory proteins PA700 and PA28. {ECO:0000269|PubMed:10764772}.;
- Pathway
- Proteasome - Homo sapiens (human);Post-translational protein modification;Metabolism of proteins;UCH proteinases;Neddylation;Ub-specific processing proteases;Deubiquitination
(Consensus)
Recessive Scores
- pRec
- 0.0916
Intolerance Scores
- loftool
- 0.905
- rvis_EVS
- 0.42
- rvis_percentile_EVS
- 77.06
Haploinsufficiency Scores
- pHI
- 0.739
- hipred
- Y
- hipred_score
- 0.501
- ghis
- 0.409
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.219
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Psmf1
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- ubiquitin-dependent protein catabolic process;negative regulation of endopeptidase activity;protein deubiquitination;post-translational protein modification;negative regulation of proteasomal protein catabolic process
- Cellular component
- nucleoplasm;endoplasmic reticulum;cytosol;proteasome core complex;membrane;perinuclear region of cytoplasm
- Molecular function
- endopeptidase inhibitor activity;protein binding;protein homodimerization activity;protein heterodimerization activity;proteasome binding